The impact of the global bacille Calmette–Guérin shortage on treatment patterns: population-based data

BJU International

Volumn 121, Issue 2, 2018, Pages 169-172

  Perera, Marlon ^a,b   Papa, Nathan ^a   Christidis, Daniel ^a   McGrath, Shannon ^a   Manning, Todd ^a   Roberts, Matthew ^b   Bolton, Damien ^a   Lawrentschuk, Nathan ^a,c,d   Sengupta, Shomik ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b THE UNIVERSITY OF QUEENSLAND   (Australia)

^c AUSTIN HEALTH   (Australia)

^d PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; THERACYS; TICE; IMMUNOLOGICAL ADJUVANT;

AUSTRALIA; CANCER RECURRENCE; CARCINOMA IN SITU; DRUG EFFECT; DRUG INDICATION; HUMAN; NON MUSCLE INVASIVE BLADDER CANCER; NOTE; POPULATION RESEARCH; PRESCRIPTION; PRIMARY TUMOR; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME; TREATMENT PLANNING; BLADDER TUMOR; HEALTH CARE QUALITY; STATISTICS AND NUMERICAL DATA; SUPPLY AND DISTRIBUTION; TUMOR RECURRENCE;

ADJUVANTS, IMMUNOLOGIC; AUSTRALIA; BCG VACCINE; CARCINOMA IN SITU; CARCINOMA, TRANSITIONAL CELL; DRUG PRESCRIPTIONS; HUMANS; NEOPLASM RECURRENCE, LOCAL; STANDARD OF CARE; URINARY BLADDER NEOPLASMS;

EID: 85034225233     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.14065     Document Type: Note

References (6)

1. US Food & Drug administration. Inspections, Compliance, Enforcement, and Criminal Investigations – Sanofi Pasteur 7/12/12 Warning Letter. Available at: https://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm312929.htm. Accessed October 2017
2. Veeratterapillay R, Heer R, Johnson MI, Persad R, Bach C. High-risk non-muscle-invasive bladder cancer – therapy options during intravesical BCG shortage. Curr Urol Rep 2016; 17: 68
3. Australian Government, Department of Human Services. Pharmaceutical Benefits Schedule Item Reports, 2016. Available at: http://medicarestatistics.humanservices.gov.au/statistics/pbs_item.jsp. Accessed October 2017
4. Phillips PC, Perron P. Testing for a unit root in time series regression. Biometrika 1988; 75: 335–46
5. European Association of Urology. Statement concerning the shortage of BCG immunotherapy by the EAU Guidelines Panel on Non-muscle invasive bladder cancer, 2012. Available at: https://uroweb.org/wp-content/uploads/BCG-Press-release-NMIBC-Panel-final-Aug-13th-2012.pdf. Accessed October 2017
6. Perera M, Papa N, Kinnear N et al. Urolithiasis treatment in Australia: the age of ureteroscopic intervention. J Endourol 2016; 30: 1194–9